Diabetes and its problems
... The research was funded by Diabetes UK and conducted by Professor Dario Alessi, at the Medical Research Council Protein Phosphorylation Unit and Professor Grahame Hardie, at the Wellcome Trust Biocentre, both in Dundee. This new understanding of how AMPK is switched on in the body is likely to stimulate the development of improved drugs to treat Type 2 diabetes, which are better than current treatments at normalising blood glucose and which lack unpleasant side effects that can include stomach and intestinal problems. Eleanor Kennedy, Research Director at Diabetes UK said, “This is an exciting development. It holds out the prospect of new treatments that give better control of diabetes.